Native Mitral Stenosis Treated With Transcatheter Mitral Valve Replacement Renuka Jain, MD, Mohamed F. Algahim, MD, Tanvir K. Bajwa, MD, Bijoy K. Khandheria, MD, Daniel P. O’Hair, MD The Annals of Thoracic Surgery Volume 101, Issue 3, Pages e75-e77 (March 2016) DOI: 10.1016/j.athoracsur.2015.09.020 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Transesopheageal echocardiogram of mitral valve in Patient 1 shows (A) preintervention and (B) successful placement of Edwards Sapien XT valve (Edwards Lifesciences, Irvine, California). The Annals of Thoracic Surgery 2016 101, e75-e77DOI: (10.1016/j.athoracsur.2015.09.020) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Three-dimensional transesopheageal echocardiogram of mitral valve replacement with Edwards Sapien XT valve (Edwards Lifesciences, Irvine, California) for both (A) Patient 1 and (B) Patient 2. The Annals of Thoracic Surgery 2016 101, e75-e77DOI: (10.1016/j.athoracsur.2015.09.020) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Fluoroscopic images taken from cardiac catheterization lab in Patient 2 show the Ascendra delivery system (Edwards Lifesciences, Irvine, California) with (A) valve loaded, in apical sheath into the left ventricle; (B) balloon expansion of valve; and (C) transcatheter mitral valve replacement, fully deployed. The Annals of Thoracic Surgery 2016 101, e75-e77DOI: (10.1016/j.athoracsur.2015.09.020) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions